Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy studyBeatriz Grinsztejn, Robert A. Salata, Peter Mugyenyi et al.|The Lancet HIV|2019Cited by 39
Antiretroviral therapy and vaginally administered contraceptive hormones: a three-arm, pharmacokinetic studyKimberly K. Scarsi, Charles Wira, Yoninah Cramer et al.|The Lancet HIV|2019Cited by 22